FOLD•benzinga•June 3, 2025 at 11:13 AM

Amicus Therapeutics Announced The Publication Of A Post-hoc Analysis Of Data From The Ert-experienced Cohort Of The PROPEL Study Of Cipaglucosidase Alfa-Atga + Miglustat (Cipa+Mig) In Adults With Late-onset Pompe Disease In Muscle And Nerve

No summary available.

Read the full article from the original source for complete details and context.

Article published on June 3, 2025 by benzinga